Zachary Saxe Sager is a Boston, Massachusetts based psychiatrist with 12 years of experience in Psychiatry. He completed his graduation in 2013. and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Zachary Saxe Sager is 271243 for Hospice and Palliative Medicine in Massachusetts. His current practice location is 450 Brookline Ave, Boston. Patients can reach him at 617-632-6464 or can fax him at 617-632-6180. Zachary Saxe Sager is M.D. in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1396183125.
Zachary Saxe Sager specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Zachary Saxe Sager speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
| Name: | Zachary Saxe Sager |
| Specialization: | Psychiatry |
| Gender: | Male |
| Credentials: | M.D. |
| Experience: | 12+ years |
| Medical School Attended: | Other |
| Graduation Year: | 2013 |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 450 Brookline Ave, Boston,
Massachusetts, 02215 |
| Phone: | 617-632-6464 |
| Fax: | 617-632-6180 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 7719208883 |
| Enrollment ID: | I20171016000211 |
| NPI Number: | 1396183125 |
| NPI Enumeration Date: | 14 Jun, 2013 |
| NPI Last Update On: | 11 Apr, 2019 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Zachary Saxe Sager are as mentioned below.
| License Number | Specialization | State | Status | |
| 271243 | Hospice and Palliative Medicine | Massachusetts | Primary | |
| 271243 | Psychiatry | Massachusetts | Secondary | |
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| (220162) | | |
| (220110) | Boston, MA | Acute Care Hospital |
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Zachary Saxe Sager is associated with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Dana-farber Cancer Institute, Inc. (9133038904) | 434 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Zachary Saxe Sager
450 Brookline Ave,
Boston, Massachusetts |
| Zip: | 02215-5450 |
| Phone Number: | 617-632-6464 |
| Fax Number: | 617-632-6180 |
Patients can reach Zachary Saxe Sager at
450 Brookline Ave, Boston, Massachusetts or can
call to book an appointment on 617-632-6464.
Comments/ Reviews:
Read all the reviews posted for Zachary Saxe Sager below. You may also share your own experience with Zachary Saxe Sager. Your feedback can help others make better decisions.
**
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.